The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hairy Cell Leukemia: Cladribine Treatment and Modern Targeted Therapies

Rare indolent B-cell leukemia with characteristic morphology, BRAF V600E mutation, exceptional response to purine analogs and emerging BRAF inhibitor options

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Hairy Cell Leukemia: Cladribine Treatment and Modern Targeted Therapies?

Hairy cell leukemia is rare indolent mature B-cell leukemia accounting for approximately 2% of all leukemias.

BRAF V600E mutation occurs in essentially all classic hairy cell leukemia cases providing diagnostic and therapeutic marker.

Characteristic morphology with cytoplasmic projections, immunophenotype CD20+ CD22+ CD25+ CD11c+ CD103+ CD123+.

Hairy cell leukemia variant lacks BRAF mutation, has aggressive course, and represents distinct entity from classic disease.

Annexin A1 immunohistochemistry provides specific diagnostic marker for classic hairy cell leukemia.

Symptoms

Pancytopenia with anemia, thrombocytopenia and neutropenia from bone marrow infiltration.
Splenomegaly often massive at presentation contributes to cytopenias through hypersplenism.
Recurrent infections from neutropenia and monocytopenia represent significant complication.
Fatigue, easy bruising, bleeding, weight loss reflect cytopenias and disease burden.
Hepatomegaly and lymphadenopathy may occur but lymphadenopathy less prominent than other lymphomas.

Risk Factors

Male predominance with male-to-female ratio 4:1 and median age at diagnosis 55 years.
Environmental exposures including pesticides, herbicides have suggested associations though causality not established.
BRAF V600E mutation as universal driver mutation in classic hairy cell leukemia.
No clear hereditary predisposition though rare familial clusters reported.
Variant disease with VH4-34 immunoglobulin gene usage and worse prognosis represents distinct biology.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Pancytopenia with splenomegaly and absence of significant lymphadenopathy warrants hematology evaluation.
  • Bone marrow biopsy with immunohistochemistry, flow cytometry and BRAF mutation testing establishes diagnosis.
  • Indications for treatment include symptomatic cytopenias, bulky splenomegaly, recurrent infections, B symptoms.
  • Asymptomatic patients with stable cytopenias may be observed without immediate treatment.
  • Multidisciplinary care including hematology, infectious diseases for opportunistic infection management optimizes outcomes.

Treatment Methods

01
Cladribine 0.1 mg/kg/day continuous infusion for 7 days achieves complete response rates exceeding 80% with durable remissions.
02
Pentostatin alternative purine analog provides similar outcomes with weekly dosing and longer treatment duration.
03
Rituximab anti-CD20 monoclonal antibody combination with cladribine improves complete response and minimal residual disease eradication.
04
BRAF inhibitor vemurafenib provides treatment option for refractory disease exploiting BRAF V600E mutation.
05
Moxetumomab pasudotox CD22-directed immunotoxin for multiply relapsed disease, comprehensive supportive care including infection prophylaxis particularly Pneumocystis pneumonia and herpes virus prevention, growth factor support, monitoring for second malignancies, long-term surveillance with attention to occasional very late relapses optimizes outcomes for this exceptionally treatable rare leukemia.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.